The stock has experienced significant volatility over the past six months, with a strong rally from around $12 in October 2025 to a peak above $31 in late January 2026, followed by a sharp correction. The 6-month price change is +54.48%, significantly outperforming the S&P 500's -2.82% return over the same period, indicating strong relative strength. However, the stock has declined sharply from its recent highs, with a 1-month change of -25.21%, underperforming the broader market's -5.25% decline, and a 3-month change of -2.92%, slightly outperforming the market's -4.63% drop. The current price of $18.63 is positioned roughly in the middle of its 52-week range of $4.46 to $34.17, representing a decline of approximately 45% from the high. The price action shows a clear peak in late January followed by a downtrend into late March, with a recent modest rebound from the March lows. The stock's beta of 1.284 suggests it is more volatile than the overall market, which is consistent with the observed price swings. The stock's relative strength metrics show a mixed picture: it has dramatically outperformed the market over the past year (+219.14 points) and six months (+57.30 points), but has underperformed over the past month (-19.96 points). The recent price decline has brought the stock back to levels seen in mid-December 2025, erasing most of the gains from the January surge.

Revenue and profitability have shown dramatic improvement year-over-year. For Q4 2025, revenue was $448.1 million, representing a YoY growth of 79.5% compared to Q4 2024. Net income for the quarter was $134.4 million, a substantial increase from $11.9 million in the prior-year quarter, with the net margin expanding to 30.0% from 4.8%. Sequentially, revenue grew 9.4% from Q3 2025, and net income increased 33.5%, indicating continued positive momentum. The company's financial health appears solid. The debt-to-equity ratio is a low 0.115, indicating minimal financial leverage. The current ratio is strong at 2.72, suggesting ample liquidity to cover short-term obligations. Free cash flow for the trailing twelve months is a healthy $368.3 million, and operating cash flow for Q4 2025 was $217.1 million, providing significant financial flexibility. Operational efficiency metrics show improvement. Return on Equity (ROE) is 12.4% and Return on Assets (ROA) is 10.1%, both indicating decent profitability on capital employed. Gross margin for Q4 2025 was 52.6%, a significant improvement from 27.4% in Q4 2024, reflecting higher metal prices and/or better cost control. The operating margin for the quarter was a robust 49.0%, up from 15.3% a year ago.